Johnson & Johnson unit purchases remanufacturer SterilMed

Dave Pearson | | Health Imaging | Enterprise Imaging
Ethicon Endo-Surgery, a surgical device unit of Johnson & Johnson, has announced plans to buy SterilMed, a privately-held company that remanufactures and sells pre-owned medical equipment.

Maple Grove, Minn.-based SterilMed will be managed as part of the Ethicon Endo-Surgery franchise, according to a company statement, but will continue to operate as a standalone company and retain the name SterilMed.

Ethicon, which is headquartered in Cincinnati, did not disclose terms of the deal.

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

Radiology practice's communication failure bears tragic consequences
Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Rads are more accurate when they have access to patients' self-reported symptoms

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.